N/A
N=3
Robotic Hand Orthosis Providing Grasp Assistance for Patients With Brachial Plexus Injuries
Brachial Plexus Injury
Bottom Line
View on ClinicalTrials.gov: NCT04939233 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Number of Successful Grasp Trials Per Participant Using Robotic Hand Orthosis — 13.2 Number of successful grabs of an object
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Exoskeleton glove (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Carilion Clinic
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Successful Grasp Trials Per Participant Using Robotic Hand Orthosis |
13.2 | — |
Summary
The proposed research, the development of an innovative robotic hand orthosis with intelligent grasping control, is relevant to public health as it will restore a large measure of functionality to the paralyzed hand of a person who has suffered a brachial plexus injury. The proposed orthosis will utilize novel technology that will result in a device that is compact, portable, dexterous, and intuitively controllable while overcoming the disadvantages of previously developed orthoses that rendered them difficult to use. The restoration of functionality to ones hands will significantly improve their quality of life as well as their ability to again participate in the workforce and complete dexterous activities in their daily lives.
Eligibility Criteria
Inclusion Criteria
- Brachial plexus injury to the right upper extremity
- 18 - 69 y/o with pan plexus injuries
- Lower root injuries (C7, C8, T1)
Exclusion Criteria
- No significant hand/wrist contractures or associated deformities which would affect participation
- No open wounds in affected hand or wrist
- Able to provide consent for treatment and follow general directions
- Only right-hand involved individuals will be considered, as the orthosis prototypes will be designed for right hand use only at this stage of the research
Data sourced from ClinicalTrials.gov (NCT04939233). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.